United States
Germany
Japan
United Kingdom
China
TYRO3 mouse monoclonal antibody, clone OTI4C8 (formerly 4C8)
| Applications | IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
Antibodies
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI4C2 (formerly 4C2)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Anti-PLK1 mouse monoclonal antibody, clone OTI3F12 (formerly 3F12)
| Applications | FC, IP, WB |
| Reactivities | Human, Mouse, Rat |
TYRO3 mouse monoclonal antibody, clone OTI4C8 (formerly 4C8)
| Applications | IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI4C2 (formerly 4C2)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Anti-PLK1 mouse monoclonal antibody, clone OTI8C12 (formerly 8C12)
| Applications | FC, IF, IP, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
活动过滤器
clear Category
-
Antibodies
- Primary Antibodies
优化搜索结果
Reactivities
Antibody Hosts
Knockout (KO) Validation
Clonalities
Pathways
- Oocyte meiosis (4)
- Progesterone-mediated oocyte maturation (4)
- Acute myeloid leukemia (2)
- Adherens junction (2)
- Alzheimer's disease (2)
- Axon guidance (2)
- B cell receptor signaling pathway (2)
- Bladder cancer (2)
- Cell cycle (2)
- Chemokine signaling pathway (2)
- Chronic myeloid leukemia (2)
- Colorectal cancer (2)
- Dorso-ventral axis formation (2)
- Endometrial cancer (2)
- ErbB signaling pathway (2)
- Fc epsilon RI signaling pathway (2)
- Fc gamma R-mediated phagocytosis (2)
- Focal adhesion (2)
- Gap junction (2)
- Glioma (2)
- GnRH signaling pathway (2)
- Insulin signaling pathway (2)
- Long-term depression (2)
- Long-term potentiation (2)
- MAPK signaling pathway (2)
- Melanogenesis (2)
- Melanoma (2)
- NOD-like receptor signaling pathway (2)
- Natural killer cell mediated cytotoxicity (2)
- Neurotrophin signaling pathway (2)
- Non-small cell lung cancer (2)
- Pancreatic cancer (2)
- Pathways in cancer (2)
- Prion diseases (2)
- Prostate cancer (2)
- Regulation of actin cytoskeleton (2)
- Renal cell carcinoma (2)
- T cell receptor signaling pathway (2)
- TGF-beta signaling pathway (2)
- Thyroid cancer (2)
- Toll-like receptor signaling pathway (2)
- Type II diabetes mellitus (2)
- VEGF signaling pathway (2)
- Vascular smooth muscle contraction (2)
- mTOR signaling pathway (2)
